The Advisory Committee on Immunization Practices (ACIP) has updated the recommendations [ PDF ] for using human papillomavirus (HPV) vaccine.
They include recommendations for the new bivalent HPV (types 16 and 18) vaccine (Cervarix) for females, and the quadrivalent HPV (types 6, 11, 16, and 18) vaccine (Gardasil) for females and males.
Included in the recommendations are routine vaccination of females aged 11 or 12 years with three doses of HPV vaccine, and a three-dose series of quadrivalent HPV vaccine to males aged 9 through 26 years to reduce their likelihood of acquiring genital warts.
The June issue of Texas Medicine will have more information on vaccinating young boys and men with the HPV vaccine.
Action , April 15, 2010